Related Experiment Video
Updated: Nov 18, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis
Lluís Revilla1,2, Aida Mayorgas2, Ana M Corraliza2
1Centro de Investigación Biomédica en Red de Enfermedades Hepática y Digestivas (CIBERehd), Barcelona, Spain.
We developed a new method to find links between gut microbiome, host gene expression, and clinical data in Crohn's disease. Model selection is key to uncovering these complex biological interactions for personalized medicine.
Area of Science:
- Genomics
- Microbiome Research
- Computational Biology
Background:
- Personalized medicine relies on understanding patient phenotype and predicting outcomes.
- Identifying variable interactions is challenging without prior hypotheses.
- Complex diseases like Crohn's disease involve intricate multi-omic relationships.
Purpose of the Study:
- To develop a method for identifying relationships between microbiome, host transcriptome, and clinical variables.
- To apply this method to Crohn's disease data.
- To determine the importance of model selection in multi-omic analysis.
Main Methods:
- Utilized a novel method based on canonical correlation analysis.
- Tested and optimized parameters using glioma and inflammatory bowel disease datasets.
- Applied the selected model to a Crohn's disease cohort with longitudinal sampling.
Main Results:
- Identified interactions between transcriptome, gut microbiome, and clinical variables.
- Demonstrated that model selection significantly impacts the identification of these relationships.
- Showed that incorporating clinical variables enhanced the model's explanatory power compared to co-inertia analysis.
Conclusions:
- The presented methodology offers a framework for analyzing multi-omic and clinical data interactions.
- Specific microbial and genetic factors associated with Crohn's disease were identified.
- Emphasized the critical role of appropriate model selection in multi-omics research.
More Related Videos
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: